JENNIFER GANGNIER: Open Payments
NPI 1265635155 · BRIGHTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 51 payments from 18 companies in 2025. Trend: 2023 $1,286 · 2024 $1,333 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $201 |
| ABBVIE INC. | 6 | $116 |
| UCB, Inc. | 4 | $104 |
| Arcutis Biotherapeutics, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| GENZYME CORPORATION | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $52 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
Products named: TREMFYA, Bimzelx, Zoryve, SKYRIZI, Sotyktu, DUPIXENT, COSENTYX, AKLIEF.
Industry payments across MI — which companies pay providers there.
